NanoString Technologies Inc (NASDAQ:NSTG)

9.29
Delayed Data
As of Apr 25
 -0.08 / -0.85%
Today’s Change
5.87
Today|||52-Week Range
19.30
+24.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$174.8M

Company Description

NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

Contact Information

NanoString Technologies, Inc.
530 Fairview Avenue North
Seattle Washington 98109
P:(888) 358-6266
Investor Relations:
(206) 602-1768

Employees

Shareholders

Other institutional39.33%
Mutual fund holders30.31%
Individual stakeholders26.32%

Top Executives

Robert Bradley GrayPresident, Chief Executive Officer & Director
Mary Tedd AllenSenior Vice President-Operations
Kenneth Thomas BaileyChief Financial Officer & Treasurer
Alessandra CesanoChief Medical Officer
Kathryn Surace-SmithSecretary, Vice President & General Counsel